Chemomab Therapeutics Ltd. Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Chemomab Therapeutics Ltd. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • Chemomab Therapeutics Ltd. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.01 USD/shares, a 55.6% decline year-over-year.
  • Chemomab Therapeutics Ltd. annual Earnings Per Share, Basic for 2023 was 0.1 USD/shares, a 16.5% decline from 2022.
  • Chemomab Therapeutics Ltd. annual Earnings Per Share, Basic for 2022 was 0.12 USD/shares, a 100% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0.10 $0 -16.5% Jan 1, 2023 Dec 31, 2023 20-F 2024-03-28
2022 $0.12 +$0.06 +100% Jan 1, 2022 Dec 31, 2022 20-F 2024-03-28
2021 $0.06 Jan 1, 2021 Dec 31, 2021 20-F 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.